New Zealand joins growing list of nations restricting puberty-blocking drugs for minors
New Zealand has banned puberty-blocking drugs for minors with gender dysphoria, following similar restrictions in the U.K., Finland, Sweden and Norway due to concerns over long-term safety and efficacy. The ban follows an evidence review highlighting irreversible side effects, including stunted bone growth, infertility, cognitive impairment and increased risks of cardiovascular disease, diabetes and cancer….
